Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia
Open Access
- 10 September 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (31) , 31767-31779
Abstract
Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemiaKeywords
This publication has 56 references indexed in Scilit:
- Minnelide reduces tumor burden in preclinical models of osteosarcomaCancer Letters, 2013
- The chaperone Hsp90: changing partners for demanding clientsTrends in Biochemical Sciences, 2013
- A Histone Acetyltransferase p300 Inhibitor C646 Induces Cell Cycle Arrest and Apoptosis Selectively in AML1-ETO-Positive AML CellsPLOS ONE, 2013
- The heat shock transcription factor 1 as a potential new therapeutic target in multiple myelomaBritish Journal of Haematology, 2012
- Aneuploidy causes proteotoxic stress in yeastGenes & Development, 2012
- A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic CancerScience Translational Medicine, 2012
- Heat Shock Factor Hsf1 Cooperates with ErbB2 (Her2/Neu) Protein to Promote Mammary Tumorigenesis and MetastasisJournal of Biological Chemistry, 2012
- Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate RecognitionCell, 2012
- HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human CancersCell, 2012
- Hsp90 inhibitors as novel cancer chemotherapeutic agentsTrends in Molecular Medicine, 2002